Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/4d/06/80/4d068008-4092-58f8-6592-f900e2d86508/mza_5090466875224206838.jpeg/600x600bb.jpg
RARECast
RARECast
570 episodes
6 days ago

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Show more...
Business
RSS
All content for RARECast is the property of RARECast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Show more...
Business
https://content.production.cdn.art19.com/images/78/62/a0/61/7862a061-1aa5-444e-930f-1ae380f2243f/2d4db572ece3b5f6f2226f0fd6a05549552ced99839225e9ca281c4efc9f05c4d01c0bd056920ee48155e9ac30d73d97d96d460f45cd0dd760e9a62efea54909.jpeg
Learning to Be a Caregiver and Advocate
RARECast
31 minutes 19 seconds
1 month ago
Learning to Be a Caregiver and Advocate
After Philippa Ward’s five-month-old son, Thomas, suffered infantile spasms, he was soon diagnosed with tuberous sclerosis complex—a rare genetic disorder that causes noncancerous tumors to form on various organs, including the brain. Thomas experiences near-daily seizures, cannot communicate verbally, and, due to delayed motor skills, often requires the use of a wheelchair. We spoke to Ward about her journey as the mother of a child diagnosed with tuberous sclerosis complex, the challenges posed by the condition’s complexities, and how she found both a community of support and her own voice as an advocate.
RARECast

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.